TY - JOUR
T1 - Positionspapier: Open-source-Technologie in der Behandlung von Menschen mit Diabetes mellitus - eine österreichische Perspektive Technologieausschuss der Österreichischen Diabetes Gesellschaft
T2 - Technologieausschuss der Österreichischen Diabetes Gesellschaft
AU - Kietaibl, Antonia-Therese
AU - Schuetz-Fuhrmann, Ingrid
AU - Bozkurt, Latife
AU - Fruehwald, Lisa
AU - Rami-Merhar, Birgit
AU - Froehlich-Reiterer, Elke
AU - Hofer, Sabine E.
AU - Tauschmann, Martin
AU - Resl, Michael
AU - Hoertenhuber, Thomas
AU - Stechemesser, Lars
AU - Winhofer, Yvonne
AU - Riedl, Michaela
AU - Zlamal-Fortunat, Sandra
AU - Eichner, Marlies
AU - Stingl, Harald
AU - Schelkshorn, Christian
AU - Weitgasser, Raimund
AU - Rega-Kaun, Gersina
AU - Koehler, Gerd
AU - Mader, Julia K.
N1 - Stechemesser, Weitgasser: Universitätsklinik für Innere Medizin I, Paracelsus
Medizinische Privatuniversität, Salzburg, Österreich;
PY - 2024/7
Y1 - 2024/7
N2 - People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic control as well as the quality of life. Due to barriers in the availability of AID-systems, the use and development of open-source AID-systems have internationally increased. This technology provides a necessary alternative to commercially available products, especially when approved systems are inaccessible or insufficiently adapted to the specific needs of the users. Open-source technology is characterized by worldwide free availability of codes on the internet, is not officially approved and therefore the use is on the individual's own responsibility. In the clinical practice a lack of expertise with open-source AID technology and concerns about legal consequences, lead to conflict situations for health-care professionals (HCP), sometimes resulting in the refusal of care of people living with diabetes mellitus. This position paper provides an overview of the available evidence and practical guidance for HCP to minimize uncertainties and barriers. People living with diabetes mellitus must continue to be supported in education and diabetes management, independent of the chosen diabetes technology including open-source technology. Check-ups of the metabolic control, acute and chronic complications and screening for diabetes-related diseases are necessary and should be regularly carried out, regardless of the chosen AID-system and by a multidisciplinary team with appropriate expertise.
AB - People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic control as well as the quality of life. Due to barriers in the availability of AID-systems, the use and development of open-source AID-systems have internationally increased. This technology provides a necessary alternative to commercially available products, especially when approved systems are inaccessible or insufficiently adapted to the specific needs of the users. Open-source technology is characterized by worldwide free availability of codes on the internet, is not officially approved and therefore the use is on the individual's own responsibility. In the clinical practice a lack of expertise with open-source AID technology and concerns about legal consequences, lead to conflict situations for health-care professionals (HCP), sometimes resulting in the refusal of care of people living with diabetes mellitus. This position paper provides an overview of the available evidence and practical guidance for HCP to minimize uncertainties and barriers. People living with diabetes mellitus must continue to be supported in education and diabetes management, independent of the chosen diabetes technology including open-source technology. Check-ups of the metabolic control, acute and chronic complications and screening for diabetes-related diseases are necessary and should be regularly carried out, regardless of the chosen AID-system and by a multidisciplinary team with appropriate expertise.
KW - Automated insulin delivery systems
KW - Diabetes mellitus
KW - Diabetes technology
KW - Do it yourself pancreas system
KW - Open-source technology
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pmu_pure&SrcAuth=WosAPI&KeyUT=WOS:001300694000001&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1007/s00508-024-02400-x
DO - 10.1007/s00508-024-02400-x
M3 - Originalarbeit
C2 - 39196351
SN - 0043-5325
VL - 136
SP - 467
EP - 477
JO - WIENER KLINISCHE WOCHENSCHRIFT
JF - WIENER KLINISCHE WOCHENSCHRIFT
IS - SUPPL 9
ER -